Do Endotypes Predict Response and Sequelae in OSA Patients
Phase 2
200
about 6.4 years
21–65
1 site in CA
About this study
This trial is testing whether different underlying causes of Obstructive Sleep Apnea (OSA) predict how well people respond to treatment and what problems the disease might cause. The goal is to understand if knowing these 'endotypes' can help doctors choose the best way to treat each individual with OSA.
Based on ClinicalTrials.gov records.
What participants do
- 1.Supplemental Oxygen
- 2.Take Eszopiclone
- 3.Use Continuous Positive Airway Pressure (CPAP)
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
eszopiclone, VARIOUS
oral (Oral Tablet)
Secondary: Brief Pain Inventory (Short Form), Diastolic Blood Pressure, Epworth Sleepiness Scale (ESS), Functional Assessment of Chronic Illness Therapy Fatigue Scale (FACIT-F), Insomnia Severity Index (ISI), PROMIS (Patient-Reported Outcomes Measurement Information System) pain intensity, PROMIS (Patient-Reported Outcomes Measurement Information System) pain interference, Pittsburgh Sleep Quality Index (PSQI)
therapeutic